OSCR Relative Valuation
OSCR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, OSCR is overvalued; if below, it's undervalued.
Historical Valuation
Oscar Health Inc (OSCR) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.29 is considered Undervalued compared with the five-year average of 29.99. The fair price of Oscar Health Inc (OSCR) is between 15.11 to 20.12 according to relative valuation methord. Compared to the current price of 14.02 USD , Oscar Health Inc is Undervalued By 7.21%.
Relative Value
Fair Zone
15.11-20.12
Current Price：14.02
7.21%
Undervalued
-7.83
PE
1Y
3Y
5Y
Trailing
Forward
-5.94
EV/EBITDA
Oscar Health Inc. (OSCR) has a current EV/EBITDA of -5.94. The 5-year average EV/EBITDA is 1.52. The thresholds are as follows: Strongly Undervalued below -15.68, Undervalued between -15.68 and -7.08, Fairly Valued between 10.11 and -7.08, Overvalued between 10.11 and 18.71, and Strongly Overvalued above 18.71. The current Forward EV/EBITDA of -5.94 falls within the Historic Trend Line -Fairly Valued range.
-4.26
EV/EBIT
Oscar Health Inc. (OSCR) has a current EV/EBIT of -4.26. The 5-year average EV/EBIT is 4.25. The thresholds are as follows: Strongly Undervalued below -20.55, Undervalued between -20.55 and -8.15, Fairly Valued between 16.65 and -8.15, Overvalued between 16.65 and 29.05, and Strongly Overvalued above 29.05. The current Forward EV/EBIT of -4.26 falls within the Historic Trend Line -Fairly Valued range.
0.29
PS
Oscar Health Inc. (OSCR) has a current PS of 0.29. The 5-year average PS is 0.51. The thresholds are as follows: Strongly Undervalued below -0.55, Undervalued between -0.55 and -0.02, Fairly Valued between 1.04 and -0.02, Overvalued between 1.04 and 1.57, and Strongly Overvalued above 1.57. The current Forward PS of 0.29 falls within the Historic Trend Line -Fairly Valued range.
6.29
P/OCF
Oscar Health Inc. (OSCR) has a current P/OCF of 6.29. The 5-year average P/OCF is -6.91. The thresholds are as follows: Strongly Undervalued below -70.93, Undervalued between -70.93 and -38.92, Fairly Valued between 25.10 and -38.92, Overvalued between 25.10 and 57.11, and Strongly Overvalued above 57.11. The current Forward P/OCF of 6.29 falls within the Historic Trend Line -Fairly Valued range.
-5.02
P/FCF
Oscar Health Inc. (OSCR) has a current P/FCF of -5.02. The 5-year average P/FCF is 4.12. The thresholds are as follows: Strongly Undervalued below -44.49, Undervalued between -44.49 and -20.19, Fairly Valued between 28.43 and -20.19, Overvalued between 28.43 and 52.73, and Strongly Overvalued above 52.73. The current Forward P/FCF of -5.02 falls within the Historic Trend Line -Fairly Valued range.
Oscar Health Inc (OSCR) has a current Price-to-Book (P/B) ratio of 2.58. Compared to its 3-year average P/B ratio of 2.52 , the current P/B ratio is approximately 2.47% higher. Relative to its 5-year average P/B ratio of 2.20, the current P/B ratio is about 17.33% higher. Oscar Health Inc (OSCR) has a Forward Free Cash Flow (FCF) yield of approximately 34.49%. Compared to its 3-year average FCF yield of 13.27%, the current FCF yield is approximately 159.91% lower. Relative to its 5-year average FCF yield of 9.33% , the current FCF yield is about 269.65% lower.
2.58
P/B
Median3y
2.52
Median5y
2.20
34.49
FCF Yield
Median3y
13.27
Median5y
9.33
Competitors Valuation Multiple
The average P/S ratio for OSCR's competitors is 0.34, providing a benchmark for relative valuation. Oscar Health Inc Corp (OSCR) exhibits a P/S ratio of 0.29, which is -14.57% above the industry average. Given its robust revenue growth of 42.20%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of OSCR decreased by 25.79% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 2.14B to 3.05B.
The secondary factor is the Margin Expansion, contributed 9.18%to the performance.
Overall, the performance of OSCR in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
FAQ
Is Oscar Health Inc (OSCR) currently overvalued or undervalued?
What is Oscar Health Inc (OSCR) fair value?
How does OSCR's valuation metrics compare to the industry average?
What is the current P/B ratio for Oscar Health Inc (OSCR) as of Aug 05 2025?
What is the current FCF Yield for Oscar Health Inc (OSCR) as of Aug 05 2025?
What is the current Forward P/E ratio for Oscar Health Inc (OSCR) as of Aug 05 2025?